← Leaderboards
Vincent P Willard
Cytex Therapeutics Inc.
$732,265
Attributed
$732,265
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $282.3K · FY2017–23$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$732,265 · 3
By mechanism
R43$450,000 · 2
R41$282,265 · 1
Top collaborators
No co-investigators on record.
Most similar at Cytex Therapeutics Inc.
Same institution · by research overlap
- Bradley T Estes$10,927,005
Others in their field
Other Emerging Leaders on “Replacement Arthroplasty”
- Hilal Maradit Kremers · Mayo Clinic Rochester$11,237,819
- Hang Lin · University Of Pittsburgh At Pittsburgh$5,442,469
- Steven P Cohen · Johns Hopkins University$4,637,929
- Christine Ann Pellegrini · University Of South Carolina At Columbia$4,252,728
- Maddalena Adorno · Dorian Therapeutics, Inc.$4,178,124
- Julien Mamet · Adynxx, Inc.$3,461,060
Research focus
Replacement ArthroplastyCytokineMechanicsRepairedUnited StatesOperative Surgical ProceduresIn VitroMechanical PropertiesDegenerative PolyarthritisPatient PopulationEconomic BurdenTissuesDisabilityPainCartilageInflammatoryJointsLongevityAdultEtiologyAffectImageEngineeringEnsure
Grant awards (3)
Addressing bone marrow lesions that compromise osteochondral tissue repair$282,265
R41 · FY2023 · AR · contact PI
Evaluating the Safety and Efficacy of Cartilage Regeneration with Tunable Inflammation Resistance$225,000
R43 · FY2018 · AR · contact PI
A 3D osteoarthritis model targeting patient populations with high risk genetic polymorphisms$225,000
R43 · FY2017 · AR · contact PI